World CNS Series

Upcoming Events in the World CNS Series

Providing Industry-Dedicated Content & Uniting CNS Drug Developers

Following a year of significant pharma acquisitions, approvals of transformative drugs the first of their kind, and a surge of financial backing to bolster innovation in new targets and preclinical pipelines, 2025 is set to continue this momentum, with more companies prioritizing neuroscience drug development than ever before, thanks to:

  • Huge breakthroughs in neuroscience discovery with state-of-the-art screening technologies
  • In vitro preclinical model advances, including 3D brain organoids and IPSC-derived microglia
  • Implementation of novel blood-based and digital biomarkers for non-invasive and objective measurements
  • Next-generation rodent, pig, and NHP models with enhanced human relevance and translatability
  • Brand new drug delivery innovations to overcome the blood-brain barrier and unlock deeper brain regions
  • Clinical innovations to navigate heterogeneous patient populations, streamline recruitment, and navigate regulatory challenges

Relive the Highlights From Onsite

Delivering & Translating Degraders of Extracellular & Intracellular CNS Proteins

Translating Neuroimmunological Targets & Neuroinflammatory Biomarkers to Revolutionize Neurological Drug Development

Uniting CNS Biopharma to Revolutionize the Next Wave of Neurodegenerative Therapeutics

Revolutionizing ALS Biomarkers to Accelerate the Translation of Efficacious Drugs into Clinic

Enhance Delivery & Distribution of Safe & Potent Oligonucleotides to the CNS

Innovating Precision Neuropsychiatry & Propelling Next Generation Drug R&D

Discovering, Validating & Implementing Novel Translatable Neuroinflammatory & Neurodegenerative Biomarkers

Advancing Translatable Systemic & Local Delivery Systems to Maximize CNS Uptake & Safely Administer to Specific Brain Regions

Get a comprehensive overview of the upcoming events within the World CNS Series portfolio. If you have any questions, get in touch at info@hansonwade.com